Serum CRP, IL-1β, IL-6 and TNF-α [55,58,59,63,66,70,71], liver TBARS, IL-1β, IL-6 and TNF-α [47,55,68], adipose IL-1β and TNF-α [70], pancreatic TBARS, AGE, LDH, CRP and IL-1β [56], and heart and kidney IL-6, TBARS levels were all reduced by HT treatment [65]. The gene discussed is IL6; the disease is hematocrit.